{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:48:18Z","timestamp":1768484898460,"version":"3.49.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroscience Methods"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jneumeth.2018.05.020","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T12:45:12Z","timestamp":1527597912000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Pharmacology of epileptogenesis and related comorbidities in the WAG\/Rij rat model of genetic absence epilepsy"],"prefix":"10.1016","volume":"310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-8123","authenticated-orcid":false,"given":"Emilio","family":"Russo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Citraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneumeth.2018.05.020_bib0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.devbrainres.2004.10.001","article-title":"The effects of the immature rat model of febrile seizures on the occurrence of later generalized tonic-clonic and absence epilepsy","volume":"154","author":"Ate\u015f","year":"2005","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0010","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1528-1167.2012.03462.x","article-title":"The system epilepsies: a pathophysiological hypothesis","volume":"53","author":"Avanzini","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0015","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","article-title":"Serotonin and epilepsy","volume":"100","author":"Bagdy","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12551","article-title":"Long-term seizure remission in childhood absence epilepsy: might initial treatment matter?","volume":"55","author":"Berg","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eplepsyres.2004.12.001","article-title":"Distribution of D1-like and D2-like dopamine receptors in the brain of genetic epileptic WAG\/Rij rats","volume":"63","author":"Birioukova","year":"2005","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0030","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1528-1167.2007.01458.x","article-title":"Early treatment suppresses the development of spike-wave epilepsy in a rat model","volume":"49","author":"Blumenfeld","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/epi.12298","article-title":"Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy","volume":"54","author":"Brooks-Kayal","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0040","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/j.1528-1167.2008.01680.x","article-title":"Childhood absence epilepsy: behavioral, cognitive, and linguistic comorbidities","volume":"49","author":"Caplan","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0045","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/bph.12052","article-title":"Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?","volume":"168","author":"Cardamone","year":"2013","journal-title":"Br J. Pharmacol."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nbd.2013.11.020","article-title":"Chronic antidepressant treatment accelerates kindling epileptogenesis in rats","volume":"63","author":"Cardamone","year":"2014","journal-title":"Neurobiol Dis."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0055","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.neuropharm.2006.06.014","article-title":"Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG\/Rij rats, an animal model of generalized absence epilepsy","volume":"51","author":"Citraro","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eplepsyres.2011.02.013","article-title":"Preclinical activity profile of \u03b1-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy","volume":"95","author":"Citraro","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0065","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14728222.2014.874416","article-title":"Targeting \u03b1-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy","volume":"18","author":"Citraro","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0070","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/epi.12686","article-title":"Protective effects of some statins on epileptogenesis and depressive-like behavior in WAG\/Rij rats, a genetic animal model of absence epilepsy","volume":"55","author":"Citraro","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0075","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1111\/bph.13121","article-title":"Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG\/Rij rat model of absence epilepsy","volume":"172","author":"Citraro","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.02.004","article-title":"Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG\/Rij rats","volume":"113","author":"Citraro","year":"2015","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.phrs.2016.03.039","article-title":"MTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis","volume":"107","author":"Citraro","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0090","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/epi.13629","article-title":"Perampanel effects in the WAG\/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior","volume":"58","author":"Citraro","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0095","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1023\/A:1026179013847","article-title":"Genetic animal models for absence epilepsy: a review of the WAG\/Rij strain of rats","volume":"33","author":"Coenen","year":"2003","journal-title":"Behav. Genet."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-0102(00)00154-1","article-title":"Dopamine characteristics in different rat genotypes: the relation to absence epilepsy","volume":"38","author":"de Bruin","year":"2000","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neubiorev.2016.02.007","article-title":"Inflammatory mediators in human epilepsy: a systematic review and meta-analysis","volume":"63","author":"de Vries","year":"2016","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0110","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/epi.12118","article-title":"Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy","volume":"54","author":"Dezsi","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bcp.2012.08.016","article-title":"Rhythm and blues: animal models of epilepsy and depression comorbidity","volume":"85","author":"Epps","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0120","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1528-1167.2012.03506.x","article-title":"Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target","volume":"53","author":"Galanopoulou","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pbb.2012.08.025","article-title":"Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model","volume":"103","author":"Gao","year":"2012","journal-title":"Pharmacol. Biochem Behav."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0130","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.0013-9580.2004.13104.x","article-title":"Chromosomal mapping of genetic loci controlling absence epilepsy phenotypes in the WAG\/Rij rat","volume":"45","author":"Gauguier","year":"2004","journal-title":"Epilepsia."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/1073858409354385","article-title":"Is epilepsy a preventable disorder? New evidence from animal models","volume":"16","author":"Giblin","year":"2010","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejps.2016.09.016","article-title":"Fingolimod enhances myelin repair of hippocampus in pentylenetetrazol-induced kindling model","volume":"96","author":"Gol","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0145","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrn3482","article-title":"Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction","volume":"14","author":"Goldberg","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuroscience.2015.04.033","article-title":"Cognitive impairments and neuronal injury in different brain regions of a genetic rat model of absence epilepsy","volume":"298","author":"Jafarian","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0155","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1093\/cercor\/bhx174","article-title":"Building up absence seizures in the somatosensory cortex: from network to cellular epileptogenic processes","volume":"27","author":"Jarre","year":"2017","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0160","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.yebeh.2016.01.029","article-title":"Proconvulsant effects of antidepressants \u2014 what is the current evidence?","volume":"61","author":"Johannessen Landmark","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0165","first-page":"741","article-title":"Deficit of endogenous kynurenic acid in the frontal cortex of rats with a genetic form of absence epilepsy","volume":"55","author":"Kami\u0144ski","year":"2003","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0170","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ncl.2009.08.002","article-title":"Depression and epilepsy: a review of multiple facets of their close relation","volume":"27","author":"Kanner","year":"2009","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1744-9081-8-51","article-title":"Age-dependent decline in learning and memory performances of WAG\/Rij rat model of absence epilepsy","volume":"8","author":"Karson","year":"2012","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainresbull.2012.07.010","article-title":"Neonatal tricyclic antidepressant clomipramine treatment reduces the spike-wave discharge activity of the adult WAG\/Rij rat","volume":"89","author":"Kov\u00e1cs","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0185","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0190","series-title":"Molecules to Medicine with MTOR: Translating Critical Pathways into Novel Therapeutic Strategies","first-page":"123","article-title":"mTOR signaling in epilepsy and epileptogenesis: preclinical and clinical studies","author":"Leo","year":"2016"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0195","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s13311-017-0550-y","article-title":"Fingolimod exerts only temporary antiepileptogenic effects but longer-lasting positive effects on behavior in the WAG\/Rij rat absence epilepsy model","volume":"14","author":"Leo","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0200","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/1871527315666161104163031","article-title":"The sphingosine 1-phosphate signaling pathway in epilepsy: a possible role for the immunomodulator drug fingolimod in epilepsy treatment","volume":"16","author":"Leo","year":"2017","journal-title":"CNS Neurol. Disord. \u2013 Drug. Targets"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0205","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022798","article-title":"Common mechanisms underlying epileptogenesis and the comorbidities of epilepsy","volume":"6","author":"Mazarati","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0006-8993(01)02705-6","article-title":"Electrophysiological and pharmacological characteristics of two types of spike-wave discharges in WAG\/Rij rats","volume":"911","author":"Midzianovskaia","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0215","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.brainresbull.2006.03.008","article-title":"The brain 5HTergic response to an acute sound stress in rats with generalized (absence and audiogenic) epilepsy","volume":"69","author":"Midzyanovskaya","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0220","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmed.2015.03.006","article-title":"Sphingosine 1-phosphate signaling at the blood-brain barrier","volume":"21","author":"Prager","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0225","doi-asserted-by":"crossref","DOI":"10.1111\/j.0013-9580.2004.50303.x","article-title":"Polygenic control of idiopathic generalized epilepsy phenotypes in the genetic absence rats from Strasbourg (GAERS)","author":"Rudolf","year":"2004","journal-title":"Epilepsia"},{"issue":"26","key":"10.1016\/j.jneumeth.2018.05.020_bib0230","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ijdevneu.2008.07.002","article-title":"Effects of ethanol on the development of genetically determined epilepsies in rats","author":"Russo","year":"2008","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0235","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.yebeh.2008.04.018","article-title":"Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy","volume":"13","author":"Russo","year":"2008","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0240","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/j.1528-1167.2009.02400.x","article-title":"Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy","volume":"51","author":"Russo","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0245","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1528-1167.2011.03112.x","article-title":"Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model","volume":"52","author":"Russo","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0250","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbr.2011.07.030","article-title":"Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity","volume":"225","author":"Russo","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0255","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s12035-012-8314-5","article-title":"The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis","volume":"46","author":"Russo","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0260","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1517\/13543784.2012.705277","article-title":"New AMPA antagonists in epilepsy","volume":"21","author":"Russo","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0265","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuroscience.2012.09.021","article-title":"Protective activity of alpha-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis","volume":"226","author":"Russo","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuropharm.2012.09.019","article-title":"MTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy","volume":"69","author":"Russo","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2012.12.002","article-title":"Pharmacodynamic potentiation of antiepileptic drugs\u2019 effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA\/2 mice","volume":"70","author":"Russo","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0280","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbi.2014.06.016","article-title":"Early molecular and behavioral response to lipopolysaccharide in the WAG\/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT\/mTOR pathways and neuroinflammatory cytokine release","volume":"42","author":"Russo","year":"2014","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0285","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s10072-014-1842-1","article-title":"The mTOR signaling pathway and neuronal stem\/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model","volume":"35","author":"Russo","year":"2014","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0290","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.neubiorev.2016.09.017","article-title":"Upholding WAG\/Rij rats as a model of absence epileptogenesis: hidden mechanisms and a new theory on seizure development","volume":"71","author":"Russo","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0295","article-title":"Maternal care exerts disease-modifying effects on genetic absence epilepsy and comorbid depression","volume":"31","author":"Sarkisova","year":"2018","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbr.2005.07.024","article-title":"Behavioral characteristics of WAG\/Rij rats susceptible and non-susceptible to audiogenic seizures","volume":"166","author":"Sarkisova","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0305","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.pnpbp.2010.11.010","article-title":"The WAG\/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression","volume":"35","author":"Sarkisova","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0310","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11055-008-0017-z","article-title":"Dopamine-dependent nature of depression-like behavior in WAG\/Rij rats with genetic absence epilepsy","volume":"38","author":"Sarkisova","year":"2008","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0315","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1528-1167.2009.02260.x","article-title":"Spike-wave discharges are necessary for the expression of behavioral depression-like symptoms","volume":"51","author":"Sarkisova","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0320","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1134\/S0012496617020077","article-title":"Rearing by foster Wistar mother with high level of maternal care counteracts the development of genetic absence epilepsy and comorbid depression in WAG\/Rij rats","volume":"473","author":"Sarkisova","year":"2017","journal-title":"Dokl. Biol. Sci."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0325","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2174\/1389450116666150330114850","article-title":"Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions","volume":"16","author":"Scicchitano","year":"2015","journal-title":"Curr. Drug. Targets"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0330","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/ene.12428","article-title":"Statins are associated with decreased mortality risk after status epilepticus","volume":"22","author":"Sierra-Marcos","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0335","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.brainres.2010.12.067","article-title":"Neonatal sensory deprivation promotes development of absence seizures in adult rats with genetic predisposition to epilepsy","volume":"1377","author":"Sitnikova","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0340","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.brainres.2014.10.067","article-title":"Reduction of epileptic spike-wave activity in WAG\/Rij rats fostered by Wistar dams","volume":"1594","author":"Sitnikova","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0345","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.eplepsyres.2004.03.001","article-title":"MAOA knockout mice are more susceptible to seizures but show reduced epileptogenesis","volume":"59","author":"Teskey","year":"2004","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0350","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/neu.10291","article-title":"Differential expression of high voltage-activated Ca2+ channel types in the rostral reticular thalamic nucleus of the absence epileptic WAG\/ Rij rat","volume":"58","author":"Van De Bovenkamp-Janssen","year":"2004","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0355","article-title":"Experimental treatment options in absence epilepsy","volume":"23","author":"van Luijtelaar","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0360","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2174\/0929867320666131119152913","article-title":"Progress and outlooks in a genetic absence epilepsy model (WAG\/Rij)","volume":"21","author":"van Luijtelaar","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0365","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11062-012-9252-6","article-title":"Cytokines and absence seizures in a genetic rat model","volume":"43","author":"Van Luijtelaar","year":"2012","journal-title":"Neurophysiology"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0370","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nbd.2013.08.013","article-title":"Anti-epileptogenesis: electrophysiology, diffusion tensor imaging and behavior in a genetic absence model","volume":"60","author":"Van Luijtelaar","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0375","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1528-1167.2011.03073.x","article-title":"Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy","volume":"52","author":"van Vliet","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0380","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2012.04.004","article-title":"The role of inflammation in epileptogenesis","volume":"69","author":"Vezzani","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0385","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0028-3908(88)90043-3","article-title":"Effects of drugs affecting dopaminergic neurotransmission in rats with spontaneous petit mal-like seizures","volume":"27","author":"Warter","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0390","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.22186","article-title":"Fingolimod provides long-term protection in rodent models of cerebral ischemia","volume":"69","author":"Wei","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0395","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s13311-013-0250-1","article-title":"Searching for the ideal antiepileptogenic agent in experimental models: single treatment versus combinatorial treatment strategies","volume":"11","author":"White","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jneumeth.2018.05.020_bib0400","article-title":"Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"}],"container-title":["Journal of Neuroscience Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027018301584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027018301584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:46:49Z","timestamp":1759020409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165027018301584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":80,"alternative-id":["S0165027018301584"],"URL":"https:\/\/doi.org\/10.1016\/j.jneumeth.2018.05.020","relation":{},"ISSN":["0165-0270"],"issn-type":[{"value":"0165-0270","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacology of epileptogenesis and related comorbidities in the WAG\/Rij rat model of genetic absence epilepsy","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroscience Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneumeth.2018.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}